Definitive Biotechnologies LLC — Department of Defense SBIR Phase II: AF203-DCSO1
Definitive Biotechnologies LLC — SBIR Phase II award from Department of Defense.
- Amount
- $749,991
- Agency
- Department of Defense · Air Force
- Program / Phase
- SBIR · Phase II
- Topic
- AF203-DCSO1
- Solicitation
- X20.3
- NAICS
- —
- Place of performance
- MD
- Period
- 2021-03-09 → 2022-06-15
Description
Definitive is a startup biotechnology company, based in Maryland. Our focus is the development of medical devices that are consistent with public health use. We have licensed a technology from the University of Pennsylvania to develop a low-cost disposabl